机译:免疫球蛋白加上泼尼松酮的功效预防严重川崎病患者冠状动脉异常(提高研究):随机,开放标签,盲终点试验
Department of Pediatrics Gunma University Graduate School of Medicine Gunma 371-8511 Japan;
First Department of Pediatrics Toho University Omori Medical Center Tokyo Japan;
Department of Health Policy National Center for Child Health and Development Tokyo Japan;
Faculty of Education Saitama University Saitama Japan;
Clinical Investigation and Research Unit Gunma University Hospital Gunma Japan;
Department of Pediatrics Gunma University Graduate School of Medicine Gunma 371-8511 Japan;
Department of Pediatrics Nagoya University Graduate School of Medicine Nagoya Japan;
Department of Pediatrics Kyusyu University Graduate School of Medical Sciences Fukuoka Japan;
Department of Pediatric Cardiology and Nephrology Kyoto Prefectural University of Medicine;
Department of Pediatrics Nippon Medical School Tokyo Japan;
Department of Cardiology Tokyo Metropolitan Children's Medical Center Tokyo Japan;
Department of Pediatrics Kagoshima University Graduate School of Medicine and Dental Sciences;
Department of Pediatrics NTT East Japan Sapporo Hospital Sapporo Japan;
Department of Pediatrics Toyama University Toyama Japan;
Department of Cardiology Gunma Children's Medical Center Gunma Japan;
Department of Pediatrics Nippon Medical School Tokyo Japan Department of Pediatrics Nippon;
Department of Pediatrics St Luke's International Hospital Tokyo Japan;
Department of Pediatrics Fukuoka Higashi Medical Center Fukuoka Japan;
Department of Pediatrics Nagoya Memorial Hospital Nagoya Japan;
First Department of Pediatrics Toho University Omori Medical Center Tokyo Japan;
Department of Pediatrics Toyota Memorial Hospital Toyota Japan;
Department of Pediatrics Gunma University Graduate School of Medicine Gunma 371-8511 Japan;
机译:免疫球蛋白加上泼尼松酮的功效预防严重川崎病患者冠状动脉异常(提高研究):随机,开放标签,盲终点试验
机译:Readrug Alert Journal Club - 关于:免疫球蛋白加上抗葡萄球菌的疗效治疗严重川崎病患者冠状动脉异常的疗效(提高研究):随机,开放标签,盲终点试验
机译:用免疫球蛋白加上川孢菌素预防川崎病患者冠状动脉异常的疗效预计患者的冠状动脉异常(KAICA研究)的风险增加(KAICA研究):一个受控,第3阶段,随机,开放标签,盲终点试验
机译:川崎病造成的冠状动脉狭窄冠状动脉旁路移植
机译:川崎病的心率,对静脉免疫球蛋白的反应性和冠状动脉瘤
机译:一项III期多中心随机开放标签盲点试验的研究方案以评估免疫球蛋白联合环孢菌素A在严重川崎病患者中的疗效和安全性(KAICA试验)
机译:307.用免疫球蛋白加上川孢菌素加冠状动脉异常预测川崎病患者的冠状动脉异常的疗效预计是IVIG非反应的风险增加(KAICA研究):一个受控,第3阶段,随机,开放标签,盲 - 终点试验